Drożdż K,Nabrdalik K,Hajzler W,Kwiendacz H,Gumprecht J,Lip GY .2021 .Metabolic-associated fatty liver disease (MAFLD), diabetes, and cardiovascular disease: Associations with fructose metabolism and gut microbiota. Nutrients, 14 : 103-7.
Targher G,Byrne CD,Tilg H. NAFLD .2020 .and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms, and pharmacological implications. Gut, 69 : 1691-705.
Cai J,Lin C,Lai S,Liu Y,Liang M,Qin Y .2021 .Waist-toheight ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population. Lipids Health Dis, 20 : 1-12.
Fukuda T,Hamaguchi M,Kojima T,Hashimoto Y,Ohbora A,Kato T .2016 .The impact of non‐alcoholic fatty liver disease on incident type 2 diabetes mellitus in non‐overweight individuals. Liver Intl, 36 : 275-83.
Malek M,Khamseh ME,Chehrehgosha H,Nobarani S .2021 .Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus. Endocrine, 74 : 538-45.
Ballestri S,Zona S,Targher G,Romagnoli D,Baldelli E,Nascimbeni F .2016 .Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis. J Gastroentrol Hepatol, 31 : 936-44.
.1998 .-guidelinesidentification-evaluation-and-treatment-overweight-andobesity-adults. National Institutes of Health, National Heart, : .
Obesity .2000 .: preventing and managing the global epidemic. WHO Technical Rep Series, 894 : 1-253.
Azarbad A,Aghnia T,Gharibzadeh A,Rafati S,Hashemi SM,Zarei H .2022 .Cut-off points for anthropometric indices to screen for hypertension among Iranian adults of the BandareKong cohort: a cross-sectional study. BMC Public Health, 22 : 2064-7.
Succurro E,Marini MA,Fiorentino TV,Perticone M,Sciacqua A,Andreozzi F .2022 .Sex-specific differences in prevalence of nonalcoholic fatty liver disease in subjects with prediabetes and type 2 diabetes. Diabetes Res Clin Pract, 190 : 110027.
Musso G,Gambino R,Cassader M. .2009 .Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res, 48 : 1-26.
Bhatt HB,Smith RJ .2015 .Fatty liver disease in diabetes mellitus. Hepatobiliary Surg Nutr, 4 : 101-5.
Oz I,Bilici M,Serifoglu I,Arpaci DK,Buyukuysal M,Bayraktaroglu T. .2017 .Association of pancreas volume and insulin resistance with abdominal fat distribution in type-2 diabetes as evaluated by computed tomography. Acta Endocrinol (Buchar), 13 : 168-71.
Indulekha K,Anjana RM,Surendar J,Mohan V .2011 .Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113. Clin Biochem, 44 : 281-7.
Ge X,Zheng L,Wang M,Du Y,Jiang J. Y .2020 .a population-based observational study. BMJ Open, 10 : e036663.
Zar A,Ali SS A .2022 .Visceral Adiposity Index: A Simple Tool for Assessing Risk of Type 2 Diabetes Mellitus. J Ayub Med Coll Abbottabad, 34 : 345-50.
Dharmalingam M,Yamasandhi PG .2018 .Nonalcoholic fatty liver disease and type 2 diabetes mellitus. Indian J Endocrinol Metab, 22 : 421-5.
Radu F,Potcovaru C-G,Salmen T,Filip PV,Pop C,Fierbințeanu-Braticievici C. C .2023 .The Link between NAFLD and Metabolic Syndrome. Diagnostics, 13 : 614-8.
Vilalta A,Gutiérrez JA,Chaves S,Hernández M,Urbina S,Hompesch M. .2022 .Adipose tissue measurement in clinical research for obesity, type 2 diabetes,. NAFLD/NASH. Endocrinol Diabetes Metab J, 5 : e00335.